New vaccine support (NVS) for MEASLES

GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. GAVI helps protect children in eligible countries against measles by providing support for a second dose of measles-containing vaccine, to be introduced into the routine immunisation programme. Providing a second opportunity for measles vaccination is a very powerful tool to reach children who missed the first dose and to produce immunity in a number of persons who failed to develop measles immunity after the first dose. Support for the measles vaccine and associated injection safety materials is for a period of five years.

ID Projet
47122-18-UGA-09A-A
Statut de l'activité
2 - Implementation
Type d'aide
B02 - Contributions aux budgets réguliers des institutions multilatérales
% to Ouganda
100.00

Organisations

Funding
The Global Alliance for Vaccination and Immunisation
Extending
World Health Organisation - core voluntary contributions account (for technical assitance)
Accountable
Federal States & Local Governments
Implementing
Federal States & Local Governments
Extending
United Nations Childrens Fund

Versements par exercice fiscal, trimestre

Exercice fiscal Trimestre fiscal Montant (USD) Ouganda Montant (USD)
2018 Q2 -2,530.00 -2,530.00
2017 Q3 97,370.00 97,370.00

Engagements par exercice fiscal, trimestre

Exercice fiscal Trimestre fiscal Montant (USD) Ouganda Montant (USD)
2017 Q2 85,500.00 85,500.00

Projections de CDMT par exercice fiscal

Exercice fiscal Montant (USD) Ouganda Montant (USD)
2018 42,750.00 42,750.00
2017 42,750.00 42,750.00

Code CRS %
Lutte contre les maladies infectieuses (12250) 100.0